Hepatic Disease
8
0
0
6
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
12.5%
1 terminated out of 8 trials
85.7%
-0.8% vs benchmark
38%
3 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (8)
Ketotifen in Non-Alcoholic Fatty Liver Disease Patients
Paracetamol Metabolism Research in Postoperative Hepatic Surgery
A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders
SpyGlass Surgical Study
Evaluation of the Efficacy of Contrast Enhanced Ultrasound Compared to MRI for Differentiation of Hepatic Lesions
Prolonged Hypercoagulability Following Major Liver Resection for Malignancy
Assess Safety and Performance of the Kronos Electrocautery Device for Electrocautery Procedures Following Coaxial Biopsy Procedures
Evaluation of the Samsung LABGEO PT10 Hepatic Panel in a Point-of-Care Setting